Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
20/03/2023 23:47
March 20 (Reuters) - Northwest Biotherapeutics Inc
NWBO.PK :
* NORTHWEST BIOTHERAPEUTICS AND ADVENT BIOSERVICES ANNOUNCE
RECEIPT OF LICENSE FOR COMMERCIAL MANUFACTURING AT SAWSTON, U.K.
FACILITY
Source text for Eikon: ID:nPn3Bz1MRa
Further company coverage: NWBO.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB